Diagnos Laboratorium Utama Tbk. vs Bakrieland Development Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Bakrieland Development Tbk. trades at Rp22 (market cap 957.48B, 32.66M 24h volume). The key difference: Bakrieland Development Tbk. is far larger — about 3.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Bakrieland Development Tbk. is more actively traded (32.66M versus 129.6K). Which is the better fit depends on your goals.
| DGNS | ELTY | |
|---|---|---|
Market Cap | 308B | 957.48B |
Volume | 129.6K | 32.66M |
Lot | 1.3K | 326.61K |
Turnover | 28.71M | 718.54M |
Average Price | 221.54 | 22 |
Value | 28.71M | 718.54M |
Indicative Equilibrium Price | 230 | 22 |
Indicative Equilibrium Volume | 110 | 109.04K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →